Pediatric Gynecologic Cancers

Curr Oncol Rep. 2017 Jul;19(7):44. doi: 10.1007/s11912-017-0604-7.

Abstract

Purpose of review: Three primary categories of gynecologic cancer are found in pediatric and adolescent patients: stromal carcinomas including juvenile granulosa cell tumors and Sertoli-Leydig cell tumors, rhabdomyosarcomas arising from the vagina and cervix (sarcoma botryoides), and ovarian germ cell tumors which comprise a wide range of histologies. These entities are rare and treatment approaches have focused on decreasing late effects of chemotherapy treatment. Here, we review presentation, histologic classifications, diagnosis, and treatment recommendations for pediatric gynecologic cancers.

Recent findings: Event-free and overall survival for these cancers is high, and the goals of treatment are minimization of morbidity and preservation of fertility with unilateral salpingo-oophorectomies and limited staging. Surveillance of tumor markers after surgery is helpful in monitoring for disease progression and adjuvant chemotherapy is often reserved for patients at recurrence. Recent literature supports avoiding chemotherapy even in high-grade germ cell tumors in the pediatric population.

Keywords: Genital rhabdomyosarcoma; Human papilloma virus; Pediatric Sertoli-Leydig cell tumors; Pediatric germ cell tumors; Pediatric juvenile granulosa cell tumor; Small cell ovarian carcinoma.

Publication types

  • Review

MeSH terms

  • Adolescent
  • Biomarkers, Tumor / genetics
  • Child
  • Disease-Free Survival
  • Female
  • Genital Neoplasms, Female / drug therapy
  • Genital Neoplasms, Female / epidemiology*
  • Genital Neoplasms, Female / genetics
  • Genital Neoplasms, Female / pathology
  • Granulosa Cell Tumor / drug therapy
  • Granulosa Cell Tumor / epidemiology*
  • Granulosa Cell Tumor / genetics
  • Granulosa Cell Tumor / pathology
  • Humans
  • Rhabdomyosarcoma / drug therapy
  • Rhabdomyosarcoma / epidemiology*
  • Rhabdomyosarcoma / genetics
  • Rhabdomyosarcoma / pathology
  • Sarcoma / drug therapy
  • Sarcoma / epidemiology
  • Sarcoma / pathology
  • Sertoli-Leydig Cell Tumor / drug therapy
  • Sertoli-Leydig Cell Tumor / epidemiology*
  • Sertoli-Leydig Cell Tumor / genetics
  • Sertoli-Leydig Cell Tumor / pathology
  • Vaginal Neoplasms / drug therapy
  • Vaginal Neoplasms / epidemiology
  • Vaginal Neoplasms / pathology

Substances

  • Biomarkers, Tumor